Sign Up to like & get
recommendations!
1
Published in 2022 at "RSC Advances"
DOI: 10.1039/d2ra00905f
Abstract: To develop a specific treatment against COVID-19, we investigated silymarin–chitosan nanoparticles (Sil–CNPs) as an antiviral agent against SARS-CoV-2 using in silico and in vitro approaches. Docking of Sil and CNPs was carried out against SARS-CoV-2…
read more here.
Keywords:
sil cnps;
chitosan nanoparticles;
cnps;
silico vitro ... See more keywords